What is the debt of Epizyme this year?
Epizyme has a debt level of 133.78 USD this year.
Epizyme Debt 2024
Epizyme Debt
133.78 USD
Epizyme Dividend yield
Ticker
EPZM
ISIN
US29428V1044
WKN
A1T9L2
In 2024, Epizyme's total debt was 133.78 USD, a 0% change from the 0 USD total debt recorded in the previous year.
Epizyme Aktienanalyse
What does Epizyme do?
Epizyme Inc is an American biotechnology company specializing in the development of therapeutic products for the treatment of cancer and genetic metabolic disorders. The company was founded in 2007 in Cambridge, Massachusetts. Epizyme focuses on developing drugs that target epigenetic changes in cells, which are changes in gene expression caused by changes in DNA structure. Epizyme specializes in the development of inhibitors of histone deacetylase enzymes (HDAC), which suppress the activity of enzymes involved in cell cycle regulation, apoptosis, and DNA repair. The company is divided into different business units focusing on different therapy areas, including oncology, hematologic oncology, and genetic metabolic disorders. In the field of oncology, Epizyme develops drugs for the treatment of blood and lymphatic system cancers such as diffuse large B-cell lymphoma and T-cell lymphoma. In the field of hematologic oncology, the company develops drugs for the treatment of blood disorders like myelodysplastic syndrome and acute myeloid leukemia. In the field of genetic metabolic disorders, Epizyme develops drugs for the treatment of lysosomal storage diseases. The company's business model primarily involves developing its own therapy products and collaborating with other biopharmaceutical companies and the pharmaceutical industry. Epizyme is listed on NASDAQ under the ticker symbol EPZM and has raised over $230 million in funding. Overall, Epizyme is an innovative company with a promising pipeline of drug candidates that works closely with other industry players to achieve its goals. It has established itself as a key player in the biotechnology industry. Epizyme ist eines der beliebtesten Unternehmen auf Eulerpool.com.Debt Details
Understanding Epizyme's Debt Structure
Epizyme's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.
Year-to-Year Comparison
Analyzing Epizyme's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.
Impact on Investments
Investors pay close attention to Epizyme’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.
Interpreting Debt Fluctuations
Shifts in Epizyme’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.
Frequently Asked Questions about Epizyme Stock
What was the debt of Epizyme compared to the previous year?
The debt of Epizyme has increased by 0% compared to the previous year dropped.
What are the consequences of high debt for investors in Epizyme?
High debt can pose a risk for investors of Epizyme, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.
What are the consequences of low debt for investors of Epizyme?
Low debt means that Epizyme has a strong financial position and is able to fulfill its obligations without overburdening its finances.
How does an increase in debt from Epizyme affect the company?
An increase in debt of Epizyme can adversely affect the financial condition of the company and result in a higher burden on its finances.
How does a reduction of debt of Epizyme affect the company?
A reduction in debt of Epizyme can strengthen the company's financial position and improve its ability to meet its financial obligations.
What are some factors that influence the debt of Epizyme?
Some factors that can influence the debt of Epizyme include investments, acquisitions, operating costs, and revenue development.
Why are the debts of Epizyme so important for investors?
The debts of Epizyme are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.
What strategic measures can Epizyme take to change the debt?
To change the debt, Epizyme can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.
How much dividend does Epizyme pay?
Over the past 12 months, Epizyme paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Epizyme is expected to pay a dividend of 0 USD.
What is the dividend yield of Epizyme?
The current dividend yield of Epizyme is .
When does Epizyme pay dividends?
Epizyme pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Epizyme?
Epizyme paid dividends every year for the past 0 years.
What is the dividend of Epizyme?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Epizyme located?
Epizyme is assigned to the 'Health' sector.
Wann musste ich die Aktien von Epizyme kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Epizyme from 5/18/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/18/2024.
When did Epizyme pay the last dividend?
The last dividend was paid out on 5/18/2024.
What was the dividend of Epizyme in the year 2023?
In the year 2023, Epizyme distributed 0 USD as dividends.
In which currency does Epizyme pay out the dividend?
The dividends of Epizyme are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Epizyme stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Epizyme
Our stock analysis for Epizyme Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Epizyme Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
